Pinion Investment Advisors’s AbbVie ABBV Stock Holding History

Pinion Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$861K	Sell	3,960 -773	-16%	-$171K	0.2%	81
2025 Q4	$1.08M	Sell	4,733 -451	-9%	-$103K	0.26%	58
2025 Q3	$1.18M	Buy	5,184 +321	+7%	+$65.4K	0.32%	52
2025 Q2	$903K	Buy	4,863 +167	+4%	+$31K	0.31%	61
2025 Q1	$984K	Buy	4,696 +490	+12%	+$95.3K	0.22%	70
2024 Q4	$747K	Buy	4,206 +143	+4%	+$26.3K	0.3%	63
2024 Q3	$802K	Buy	4,063 +405	+11%	+$75.6K	0.34%	61
2024 Q2	$627K	Sell	3,658 -389	-10%	-$64.4K	0.31%	62
2024 Q1	$737K	Buy	4,047 +784	+24%	+$135K	0.38%	49
2023 Q4	$506K	Buy	+3,263	New	+$476K	0.3%	74

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pinion Investment Advisors's ABBV Position: Q1 2026 in Review

Pinion Investment Advisors reduced its AbbVie (ABBV) stake by 16% in Q1 2026, selling an estimated $171K and leaving 3,960 shares worth $861K. The position accounts for 0.2% of the portfolio, ranked #81.

Pinion Investment Advisors first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.18M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Pinion Investment Advisors held 3,960 shares of AbbVie worth $861K as of Q1 2026.
Pinion Investment Advisors sold 773 AbbVie shares in Q1 2026, an estimated $171K.
AbbVie made up 0.2% of Pinion Investment Advisors's portfolio in Q1 2026, its #81 holding.
Pinion Investment Advisors first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
Pinion Investment Advisors's AbbVie position peaked at $1.18M in Q3 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Pinion Investment Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.